Home > Insider Trading > Filing (0001209191-21-023324)

Filing Details

Accession Number:: 0001209191-21-023324
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2021-03-26 18:46:52
Reporting Period:: 2021-02-26

Accepted Time:: 2021-03-26 18:46:52
Original Submission Date:: 2021-03-02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029142	Dynavax Technologies Corp	DVAX	Pharmaceutical Preparations (2834)	330728374

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1812025	Justin Burgess	C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-12	376	$3.39	1,221	No	4	A	Direct
Common Stock	Acquisiton	2021-02-26	3,167	$0.00	4,388	No	4	M	Direct
Common Stock	Acquisiton	2021-02-26	3,906	$0.00	8,294	No	4	M	Direct
Common Stock	Acquisiton	2021-03-01	2,839	$0.00	11,133	No	4	M	Direct
Common Stock	Disposition	2021-03-01	1,325	$8.88	9,808	No	4	S	Direct
Common Stock	Disposition	2021-03-01	1,633	$8.88	8,175	No	4	S	Direct
Common Stock	Disposition	2021-03-02	1,186	$8.82	6,989	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2021-02-26	3,167	$0.00	3,167	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-02-26	3,906	$0.00	3,906	$0.00
Common Stock	Restricted Stock Unit	Disposition	2021-03-01	2,839	$0.00	2,839	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,333	No	4	M	Direct
3,906	No	4	M	Direct
0	No	4	M	Direct

Footnotes

Represents 376 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 12, 2021
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 12, 2020. Delivery of the shares in settlement of the RSUs was deferred to February 26, 2021.
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 22, 2019. Delivery of the shares in settlement of the RSUs was deferred to February 26, 2021.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of March 1, 2018.
The reporting person is reporting the sale of 1,325 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 26, 2021.
The reporting person is reporting the sale of 1,633 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 26, 2021.
The reporting person is reporting the sale of 1,186 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 1, 2021.